Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
Chandra Kumar Elechalawar,1 Md Nazir Hossen,1 Priya Shankarappa,2 Cody J Peer,2 William D Figg,2 J David Robertson,3 Resham Bhattacharya,4 Priyabrata Mukherjee1,5 1Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; 2Clinical Pharmacology Program...
Enregistré dans:
Auteurs principaux: | Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/00dc7e5e6b6f43c99c08922e28d657cc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies
par: Spadavecchia J, et autres
Publié: (2016) -
The unique pancreatic stellate cell gene expression signatures are associated with the progression from acute to chronic pancreatitis
par: Cheng Hu, et autres
Publié: (2021) -
IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth
par: Jiahui Li, et autres
Publié: (2021) -
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
par: Chiaki Uchida, et autres
Publié: (2021) -
Regulation of Pancreatic Fibrosis by Acinar Cell-Derived Exosomal miR-130a-3p via Targeting of Stellate Cell PPAR-γ
par: Wang Q, et autres
Publié: (2021)